全球藥物篩選市場（2023-2030）：按類型（酒精/大麻）和最終用戶（藥物測試/職場）分類的規模、佔有率、成長分析和預測

全球藥物篩選市場規模將從2021年的53億美元成長到2022年的62.2億美元，預測期內年複合成長率為17.3%，預計到2030年將達到261.5億美元。

全球藥物篩檢市場是醫療保健產業中快速成長的細分市場，其重點是檢測個體中是否存在藥物或其代謝物。藥物篩檢在各種環境中發揮重要作用，包括職場、醫院、體育組織和執法部門，幫助識別可能使用非法藥物或濫用處方藥的個人。這個市場是由幾個因素所驅動的。首先，世界各地藥物濫用和成癮現像日益普遍，對有效的篩檢方法產生了巨大的需求。世界各地的政府和組織越來越意識到藥物濫用的社會和經濟影響，導致強制進行藥物檢測的法規和政策增加。全球藥物篩檢市場的另一個主要促進因素是公司越來越重視職場安全和擴大實施無毒品政策。雇主越來越認知到維持無毒品職場環境的重要性，以確保員工生產力、減少事故並最大限度地減少法律責任。

本報告調查了全球藥物篩選市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及按各個細分市場和地區進行的細分。競爭形勢、主要企業概況等

目錄

• 執行摘要
• 調查方法
• 母市場分析
  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
• 關鍵市場洞察
  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 重點投資分析
  • 關鍵成功因素
  • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
  • 法規狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
• 全球藥物篩選市場：按類型
  • 市場概況
  • 酒精
  • 大麻
  • 古柯鹼
  • 鴉片類藥物
  • 安非他命/甲基安非他明
  • LSD
• 全球藥物篩選市場：依最終用戶分類
  • 市場概況
  • 藥物檢測實驗室
  • 職場
• 全球藥物篩選市場：按地區
  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
• 競爭形勢
  • 前5名企業對比
  • 主要企業市場地位
  • 主要企業的招募策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率
• 主要企業簡介
  • LabCorp
  • Quest Diagnostic
  • Abbott
  • Thermo Fisher Scientific, Inc.
  • Alfa Scientific Designs, Inc.
  • OraSure Technologies, Inc.
  • Siemens
  • F. Hoffmann-La Roche Ltd
  • MPD Inc.
  • Shimadzu Corporation
  • Lifeloc Technologies, Inc
  • Dragerwerk AG & Co. KGaA
  • Premier Biotech, Inc.
  • Omega Laboratories, Inc. (US)
  • Psychemedics Corporation (US)
  • Clinical Reference Laboratory Inc., (US)
  • American Bio Medica Corporation (US)
  • Company Overview
  • Sciteck, Inc.
  • Synens SAS

Global Drug Screening Market size was valued at USD 5.3 billion in 2021 and is poised to grow from USD 6.22 billion in 2022 to USD 26.15 billion by 2030, growing at a CAGR of 17.3% during the forecast period (2023-2030).

The global drug screening market is a rapidly growing sector within the healthcare industry that focuses on detecting the presence of drugs or their metabolites in individuals. Drug screening plays a crucial role in various settings, including workplaces, hospitals, sports organizations, and law enforcement agencies, as it helps identify individuals who may be using illicit substances or misusing prescription drugs. The market is driven by several factors. First and foremost, the rising prevalence of drug abuse and addiction worldwide has created a significant demand for effective screening methods. Governments and organizations across the globe are increasingly recognizing the social and economic impact of drug abuse, leading to stricter regulations and policies that require drug testing. Another key driver for the global drug screening market is the increasing emphasis on workplace safety and the implementation of drug-free policies by companies. Employers are increasingly realizing the importance of maintaining a drug-free work environment to ensure employee productivity, reduce accidents, and minimize legal liabilities. In conclusion, the global market is experiencing significant growth driven by factors such as the increasing prevalence of drug abuse, technological advancements, workplace safety initiatives, and sports industry requirements. As drug screening becomes more crucial in various sectors, the market is expected to continue expanding in the coming years, with ongoing advancements in testing methods and regulations playing a pivotal role in shaping its future.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Screening Market Segmental Analysis

Global Drug Screening Market is segmented by type, end-user, and region. Based on type, the market can be segmented into Alcohol, Cannabis, Cocaine, Opioids, Amphetamine and Methamphetamine, and LSD. Based on end-user, the market is segmented into drug test laboratories and workplaces. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Drug Screening Market Dynamics

Drivers of the Global Drug Screening Market

Growing Drugs Consumption

As drug screening products and services are increasingly used on the road, it is anticipated that the expanding use of illicit drugs will also hasten the market's overall expansion. Additionally, teen drug use will support market expansion. Additionally, the screening is simple to put into practise, providing flexible and successful workplace drug testing, which is also anticipated to support market expansion. One important element that is anticipated to temper the market's expansion is the rise in government spending to combat drug trafficking. Future drug screening market growth will be further accelerated by the rise in traffic accidents brought on by drugged driving and prescription medication abuse.

Restraints in the Global Drug Screening Market

Prohibition of Drug Testing

Drug testing is viewed as a violation of employee privacy in some settings, particularly the workplace, which is predicted to slow market expansion. The drug screening business is expected to be challenged by restrictions on drug use in some locations and problems with breathalyser accuracy.

Market Trends of Global Drug Screening Key

The global drug screening market is witnessing several key market trends that are shaping its growth and trajectory. Firstly, there is a growing adoption of advanced technologies in drug screening. This includes the development of more sensitive and accurate testing methods, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays, which enhance the detection capabilities of drug screening procedures. Another significant trend is the increasing focus on oral fluid drug testing. Saliva-based drug screening offers non-invasive sample collection and provides a convenient alternative to urine and blood tests. It has a shorter detection window but offers real-time drug use detection and is particularly valuable in post-accident and roadside testing scenarios. Overall, the key market trends in the drug screening industry revolve around advanced technologies, rapid on-site testing, oral fluid testing, expanded drug panels, and the integration of AI and ML. These trends reflect the industry's continuous efforts to enhance accuracy, convenience, and efficiency in drug screening processes.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Drug Screening Market by Type
  • Market Overview
  • Alcohol
  • Cannabis
  • Cocaine
  • Opioids
  • Amphetamine and Methamphetamine
  • and LSD
• Global Drug Screening Market by End-User
  • Market Overview
  • Drug testing laboratories and Workplaces
• Global Drug Screening Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • LabCorp (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Quest Diagnostics (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Abbott (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Thermo Fisher Scientific, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Alfa Scientific Designs, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • OraSure Technologies, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Siemens (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MPD Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Shimadzu Corporation (Japan)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Lifeloc Technologies, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Dragerwerk AG & Co. KGaA (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Premier Biotech, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Omega Laboratories, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Psychemedics Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Clinical Reference Laboratory Inc., (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • American Bio Medica Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ACM Global Laboratories (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sciteck, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Synens SAS (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments